Group 1 - The company is planning to issue shares and pay cash to acquire at least 51% of Guangzhou Yijie Medical Technology Co., Ltd. and raise supporting funds through related party transactions [2][3] - The company's stock will be suspended from trading starting May 22, 2025, for no more than 10 trading days due to uncertainties surrounding the transaction [2] - The company is actively advancing communication and negotiation regarding the transaction, with specific plans still being refined [3] Group 2 - During the suspension period, the company will fulfill its information disclosure obligations based on the progress of the transaction and will apply for the resumption of trading as soon as possible [3] - The transaction remains highly uncertain, and investors are advised to be cautious regarding investment risks [3]
迈普医学: 关于筹划发行股份及支付现金购买资产并募集配套资金暨关联交易事项的停牌进展公告